BOSTON, Jan. 11,
2024 /PRNewswire/ -- Haemonetics Corporation (NYSE:
HAE) announced that the Company intends to publish third quarter
fiscal year 2024 financial results at 6:00 am ET on Thursday, February 8, 2024. The Company will hold
a conference call with investors and analysts to discuss results
and answer questions at 8:00 am ET on
February 8, 2024.
The call can be accessed via teleconference at: Q3 2024
Haemonetics Corporation Earnings Conference Call. Once registration
is completed, participants will receive a dial-in number along with
a personalized PIN to access the call. While not required, it is
recommended that participants join 10 minutes prior to the event
start.
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast Link:
https://edge.media-server.com/mmc/p/unynzc8w
A replay of the conference call and webcast will be available
for one year beginning on February 8,
2024 at 11:00 am ET using the
conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company
dedicated to providing a suite of innovative medical products and
solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technology addresses important
medical markets: blood and plasma component collection, the
surgical suite and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
Investor
Contacts:
|
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
|
David Trenk,
Manager-Investor Relations
|
(781) 356-9763
|
|
(203)
733-4987
|
olga.guyette@haemonetics.com
|
|
david.trenk@haemonetics.com
|
|
|
|
Media
Contact:
|
|
|
Josh Gitelson,
Director-Global Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2024-results-february-8-2024-302033140.html
SOURCE Haemonetics Corporation